Showing results (1661-1670 of 2,407) with videos related to

Sort By:
Pageof 241
Future Medicinal Chemistry|March 13, 2025
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentialsBasma S Gabr, Abdelrahman R Shalabi, Mona F Said, et al.
Future Medicinal Chemistry|October 15, 2024
In silico studies, synthesis, characterization and in vitro studies of levosulpiride derivativesMuhammad Toseef Akram, Mohsin Abbas Khan, Irshad Ahmad, et al.
Future Medicinal Chemistry|October 14, 2024
Synthesis and evaluation of antibacterial and antibiofilm agents based on phenylamino-substituted 1,4-benzoquinonesTalita O Custodio Leite, Juliana S Novais, Beatriz Lima C de Carvalho, et al.
Future Medicinal Chemistry|August 7, 2024
Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitorsSong Yao Lv, Li Ping Cheng
Future Medicinal Chemistry|August 6, 2024
An overview of pyridazin-3(2H)-one: a core for developing bioactive agents targeting cardiovascular diseases and cancerZeinab S Abd-Rabo, Aya M Serry, Riham F George
Future Medicinal Chemistry|August 5, 2024
Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitorsChangyu Ren, Zhi Cao, Yang Liu, et al.
Future Medicinal Chemistry|July 18, 2024
New pyridopyrimidine derivatives as dual EGFR and CDK4/cyclin D1 inhibitors: synthesis, biological screening and molecular modelingFatma Ma Krakisha, Dina Ia Othman, Walaa M El Husseiny, et al.
Future Medicinal Chemistry|July 16, 2024
Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studiesAsmaa F Kassem, Mohamed A Omar, Ahmed Temirak, et al.
Future Medicinal Chemistry|July 23, 2024
Synthesis of indole-functionalized isoniazid conjugates with potent antimycobacterial and antioxidant efficacyRenu Gavadia, Jyoti Rasgania, Neetu Sahu, et al.
Future Medicinal Chemistry|July 29, 2024
The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugsLeandro Dobrachinski, Leonardo Lg Ferreira, Maria E Cirino, et al.
Pageof 241